Protein Identity and Construct
Share the protein identity, sequence or construct information, oligomeric state when known, and the form that should be recognized.
Creative Biolabs Service
Creative Biolabs provides protein aptamer selection within our aptamer discovery services for defined protein targets. We tailor target presentation, specificity controls, selection pressure, and candidate evaluation to the protein format and research goal. Projects can begin with recombinant or purified proteins and move toward prioritized candidates with agreed binding and specificity evidence.
Protein aptamer selection is a strong fit when the target is known and can be presented in a defined, controllable format. Recombinant and purified proteins are common starting materials. The best route still depends on construct design, tags or carriers, buffer, accessible epitopes, related proteins, and the downstream binding context. If purification changes the relevant protein state, Native-Context Protein Aptamer Selection may be a better starting point.
Share the protein identity, sequence or construct information, oligomeric state when known, and the form that should be recognized.
Available purified protein, buffer or formulation, tags, carriers, supports, and any handling limits help define a workable presentation.
Homologs, related proteins, tag-only controls, carrier controls, or matrix components may be useful when they reflect a real off-target risk.
Intended use, desired binding profile, and downstream evaluation determine how candidates should be prioritized.
Extend candidate evaluation with defined binding or specificity assays.
Add related proteins or other relevant counter targets when broader discrimination data are needed.
Refine a selected aptamer when sequence length, chemistry, stability, or format needs further work.
Plan additional research assays when candidate behavior must be checked in a downstream experimental context.
The same protein can behave differently as a soluble recombinant construct, a multimer, an immobilized target, or a protein carried on a support. We review which form keeps the relevant binding surface accessible and which presentation can be reproduced across selection rounds.
Tags and supports make handling easier, but they can also become unintended binding surfaces. Matched tag-only, carrier-only, or support-only controls can help distinguish target recognition from presentation artifacts when those backgrounds are relevant.
Counter targets should reflect the scientific question. Closely related homologs, family members, or formulation components are more informative than unrelated negatives. We can stage specificity pressure so useful diversity is not removed too early.
Partitioning must recover target-bound sequences while limiting carryover from non-binders and background. Stringency can be adjusted through incubation, wash, target amount, competitor, or depletion conditions, but the useful direction depends on the target presentation and pool behavior.
If a purified construct loses the relevant conformation, membrane environment, or partner-dependent surface, Native-Context Protein Aptamer Selection can preserve more of the intended protein context. The target identity remains known; only the presentation strategy changes.
Review the protein construct, available material, intended binding context, specificity risks, and the downstream research question.
Choose a target presentation and partitioning concept, then define matched support, tag, homolog, or matrix controls where needed.
Run repeated selection cycles while preserving candidate diversity and adding target-relevant specificity pressure.
Compare target and control behavior across rounds and adjust stringency when enrichment or background trends indicate a need.
Identify candidate sequences from the enriched pool and screen them against the defined protein target.
Compare candidates against the agreed specificity panel and prepare the defined data and sequence package for the next stage.
We evaluate construct format, tags, carriers, and accessible target features before fixing the selection setup.
Counter targets are chosen around the real discrimination problem, such as homologs, tag background, or related proteins.
Candidate sequences are considered in relation to direct target binding and the agreed specificity context.
Selection, characterization, and optimization can be scoped as separate stages so the project can stop or continue at a useful decision point.
Aptamers can be evaluated as binding reagents for research detection formats once suitable target binding is established.
Protein-binding aptamers can support research workflows that require selective recognition of a defined molecular target.
Candidate aptamers can be used to study target recognition or competitive binding after the relevant controls are established.
A characterized protein aptamer can be considered for downstream assay or biosensor development when the readout and sample context are defined.
Tsai and colleagues reported a 2024 SELEX study against recombinant podoplanin.1 The Figure 1 pairs the selection workflow with a BLI comparison of the initial library and the ninth-round pool, making an important distinction between running selection and measuring evidence of enrichment. Later in the study, individual sequences were tested for protein binding and specificity. It supports a practical design point for protein aptamer discovery: target presentation, enrichment monitoring, and direct candidate testing answer different questions and should not be treated as interchangeable evidence.
Defined recombinant or purified proteins are common starting points. Construct design, oligomeric state, tags, carriers, buffer, and target stability should be reviewed before the presentation method is chosen.
The amount depends on target format, presentation, partitioning, controls, and the planned number of evaluations. Share the amount available and we can assess the practical route during scoping.
Not always. Immobilized and solution-compatible approaches each have advantages and artifacts. The choice should follow protein behavior and the recognition question.
Yes. Related proteins can be valuable when the main goal is molecular discrimination. The counter panel should be chosen around the real off-target risk.
Use a native-context route when purification or recombinant presentation is likely to remove an important conformation, membrane environment, or partner-dependent feature.
Candidates can move into agreed binding and specificity evaluation, then into characterization or optimization if the research program needs more evidence.
Share your protein target, construct or format, available material, and specificity concerns. Creative Biolabs can help define a focused selection plan for your research question.